Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease

Nagoyama, H.; Hamamoto, M.; Ueda, M.; Nagashima, J.; Katoyama, Y.
February 2005
Journal of Neurology, Neurosurgery & Psychiatry;Feb2005, Vol. 76 Issue 2, p249
Academic Journal
Aim: To evaluate the reliability of[123I] meta-iodobenzylgua-nidin (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease (PD). Patients/ Methods: A series of 391 outpatients showing one or more parkinsonian-like symptoms was longitudinally followed up for accurate clinical diagnosis. MIBG scintigraphy was performed in the patients and 10 normal controls of similar age. The heart to mediastinum uptake ratio was calculated in each person, and the values were considered abnormal if they were greater than two standard deviations below the control mean. Results: MIBG uptake was decreased in most patients with PD (87.7%), and was seen in all advanced cases with Hohen-Yahr stage III or more; the sensitivity and specificity of scintigraphy for detecting PD were 87.7% and 37,4%, respectively. Surprisingly, over half of the patients without PD (66.5%) also exhibited low uptake, resulting in considerable overlap in the ratios between PD and the other disorders. Conclusion: MIBG scintigraphy is a sensitive, but not specific, test for PD. Low MIBG uptake does not necessarily indicate PD, but is essential for diagnosing advanced PD.


Related Articles

  • The 'gray zone' for the heart to mediastinum MIBG uptake ratio. Petretta, Mario; Pellegrino, Teresa; Cuocolo, Alberto // Journal of Nuclear Cardiology;Oct2014, Vol. 21 Issue 5, p921 

    No abstract available.

  • Cardiac ¹²³I-MIBG scintigraphy in patients with drug induced parkinsonism. Lee, P. H.; Kim, J. S.; Shin, D. H.; Yoon, S-N; Huh, K. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2006, Vol. 77 Issue 3, p372 

    Cardiac sympathetic dysfunction was investigated using 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy in 20 patients with drug induced parkinsonism (DIP). The mean heart to mediastinum ratio was significantly greater in patients with DIP than in those with Parkinson's disease (mean...

  • National surveys: a way to manage treatment strategies in Parkinson's disease? Pharmaceutical prescribing patterns and patient experiences of symptom control and their impact on disease. Skogar, Örjan; Nilsson, Mats; Törnhage, Carl-Johan; Lökk, Johan // Journal of Multidisciplinary Healthcare;2013, Vol. 6, p239 

    Background: The purpose of this study was to draw conclusions from patient-reported experiences in two national surveys from Scandinavia with the intention of comparing treatment strategies and increasing our knowledge of factors that affect the experiences of patients with Parkinson's disease...

  • Early-stage [123I]ß-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson’s disease. Stoffers, Diederick; Booij, Jan; Bosscher, Lisette; Winogrodzka, Ania; Wolters, Erik; Berendse, Henk // European Journal of Nuclear Medicine & Molecular Imaging;Jun2005, Vol. 32 Issue 6, p689 

    Purpose: Previous studies using dopamine transporter single-photon emission computed tomography (SPECT) to try and distinguish between patients with idiopathic Parkinson's disease (IPD) and patients with atypical parkinsonian syndromes (APS) have mainly focussed on patients with an already...

  • Parkinson's disease: a model for care. Thomas, Sue // Primary Health Care;Oct2006, Vol. 16 Issue 8, p18 

    The article discusses the applicability of the four-stage clinical pathways model for individual Parkinson's disease (PD) patient care requirements in Great Britain. The model defines the stages of PD including diagnosis, maintenance, complex and palliative. The overall structure of care model...

  • Telemedicine for delivery of health care in Parkinson's disease. Samii, Ali; Ryan-Dykes, Peggy; Tsukuda, Ruth Ann; Zink, Claudia; Franks, Romay; Nichol, W. Paul // Journal of Telemedicine & Telecare;Jan2006, Vol. 12 Issue 1, p16 

    We have used telemedicine at the Seattle Veterans Administration Medical Center to deliver follow-up care to patients with Parkinson's disease (PD). Patients were located at eight facilities which were 67–2400 km from the medical centre. Each facility had videoconferencing equipment...

  • Parkinson's disease.  // Nursing Standard;10/24/2007, Vol. 22 Issue 7, p51 

    The author discusses the challenges in treating Parkinson's disease. The main objective of the author is to identify the signs and symptoms of Parkinson's disease as well as the preclinical markers that manifest before diagnosis, and to understand the complexities of medication management and...

  • Management of the patient with newly-diagnosed Parkinson's disease. Paulson, George W. // Geriatrics;Feb1993, Vol. 48 Issue 2, p30 

    Initial therapy of a patient newly diagnosed with Parkinson's disease depends on a variety of presenting symptoms and therefore must be individualized. Some patients do not initially require any therapy or can be managed with small doses of antidepressants. Anticholinergics are useful initial...

  • Generalized motor inhibitory deficit in Parkinson's disease patients who freeze. Bissett, Patrick; Logan, Gordon; van Wouwe, Nelleke; Tolleson, Christopher; Phibbs, Fenna; Claassen, Daniel; Wylie, Scott // Journal of Neural Transmission;Dec2015, Vol. 122 Issue 12, p1693 

    Freezing of gait is a disabling symptom of Parkinson's disease (PD) that involves failure to initiate and continue motor activity appropriately. PD disrupts fronto-basal ganglia circuitries that also implement the inhibition of responses, leading to the hypothesis that freezing of gait may...


Read the Article


Sign out of this library

Other Topics